Short answer
MAXCYTE, INC. (MXCT) filed its Q1 2026 10-Q quarterly report on May 13, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $5M (down 21.6% year over year) with net income of −$5M.
Q1 2026 key financials · XBRL
- Revenue
- $5M
- −21.6% YoY
- Net income
- −$5M
- +53.7% YoY
- Operating margin
- -137.4%
- Gross margin
- 179.6%
- EPS (diluted)
- −$0.04
- +60.0% YoY
Source: XBRL data from the MAXCYTE, INC. (MXCT) Q1 2026 10-Q on SEC EDGAR. USD.
MAXCYTE, INC. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No risk-factors section provided in the submitted filing text
- No newly added risk factor or stated changes from the most recent 10-K
- No regulatory, legal, operational, competitive, market, liquidity, debt, currency, or concentration risks disclosed
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other MAXCYTE, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.